<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Barr</surname>
    <given-names>I. G.</given-names>
   </name>
   <name>
    <surname>Russell</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Besselaar</surname>
    <given-names>T. G.</given-names>
   </name>
   <name>
    <surname>Cox</surname>
    <given-names>N. J.</given-names>
   </name>
   <name>
    <surname>Daniels</surname>
    <given-names>R. S.</given-names>
   </name>
   <name>
    <surname>Donis</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2014</year>). 
  <article-title>WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.</article-title>
  <source>
   <italic>Vaccine</italic>
  </source>
  <volume>32</volume>
  <fpage>4713</fpage>â€“
  <lpage>4725</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.02.014</pub-id>
  <?supplied-pmid 24582632?>
  <pub-id pub-id-type="pmid">24582632</pub-id>
 </mixed-citation>
</ref>
